Alzamend Neuro Stock Quote ALZN - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.159

Bid

1.15

Ask

1.16

Volume

77,790

1.15 Day's Range 1.21

1.06 52 Week Range 15.06

Market Cap

6.297M

Previous Close

1.20

Open

1.19

Last Trade

1.1523

Last Trade Time

12:33:26

Financial Volume

$ 90,990

VWAP

1.1697

Average Volume (3m)

211,827

Shares Outstanding

5,432,797

Dividend Yield

PE Ratio

-0.64

Earnings Per Share (EPS)

-1.83

Revenue

Net Profit

-9.95M

Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.alzamend.com

Headquarters

Wilmington, Delaware, USA

Founded

Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was $1.20. Over the last year, Alzamend Neuro shares have traded in a share price range of $ 1.06 to $ 15.06.

Alzamend Neuro currently has 5,432,797 shares outstanding. The market capitalization of Alzamend Neuro is $6.52 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.64.

Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo

Presentation Topic is the Pharmacokinetics of AL001, a Lithium Salicylate/L-Proline Co-crystal, as a Potentially Beneficial Lithium Sparing Treatment for Bipolar Disorder Type 1, Alzheimer’s...

Form 8-K - Current report

Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs

During the six months ended October 31, 2024, net cash provided by financing activities was $8.3 million Stockholder equity of $3.8 million at October 31, 2024, including $4.1 million of cash...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Alzamend Neuro Announces Full Data Set from its Nonclinical Study: Comparing Brain and Plasma Lithium Exposures between AL001 and Lithium Carbonate in Alzheimer’s Transgenic Mice

Alzamend is developing AL001, a lithium product designed for enhanced safety and efficacy compared to currently available FDA-approved and marketed lithium therapies At a low dose, AL001...

Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

Data confirm the positive topline results announced in June 2023 identifying a maximum tolerated dose as assessed by an independent safety review committee Identified dose is unlikely to require...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.019	1.66666666667	1.14	1.2465	1.12	108730	1.19276924	CS
4	-0.161	-12.196969697	1.32	1.34	1.06	175126	1.19290258	CS
12	-0.511	-30.5988023952	1.67	1.9	1.06	211827	1.47744113	CS
26	-2.751	-70.358056266	3.91	15.06	1.06	937043	4.83908111	CS
52	-8.163	-87.5670456983	9.322	15.06	1.06	509441	5.02302114	CS
156	-279.341	-99.5868092692	280.5	366	1.06	519507	118.33492929	CS
260	-4348.841	-99.9733563218	4350	5032.5	1.06	1124012	368.90841436	CS

ALZN - Frequently Asked Questions (FAQ)

What is the current Alzamend Neuro share price?

The current share price of Alzamend Neuro is $ 1.159

How many Alzamend Neuro shares are in issue?

Alzamend Neuro has 5,432,797 shares in issue

What is the market cap of Alzamend Neuro?

The market capitalisation of Alzamend Neuro is USD 6.52M

What is the 1 year trading range for Alzamend Neuro share price?

Alzamend Neuro has traded in the range of $ 1.06 to $ 15.06 during the past year

What is the PE ratio of Alzamend Neuro?

The price to earnings ratio of Alzamend Neuro is -0.64

What is the reporting currency for Alzamend Neuro?

Alzamend Neuro reports financial results in USD

What is the latest annual profit for Alzamend Neuro?

The latest annual profit of Alzamend Neuro is USD -9.95M

What is the registered address of Alzamend Neuro?

The registered address for Alzamend Neuro is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Alzamend Neuro website address?

The website address for Alzamend Neuro is www.alzamend.com

Which industry sector does Alzamend Neuro operate in?

Alzamend Neuro operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NXUNXU Inc	$ 1.98 (713.48%)	456.34M
WATTEnergous Corporation	$ 1.538 (274.03%)	167.83M
INTZIntrusion Inc	$ 5.485 (153.94%)	115.21M
JDZGJIADE Ltd	$ 1.51 (115.65%)	7.54M
CYNCYNGN Inc	$ 1.205 (91.91%)	62.14M
ABPAbpro Holdings Inc	$ 2.1215 (-52.75%)	1.52M
TRAWTraws Pharma Inc	$ 7.77 (-42.10%)	907.82k
SHOTWSafety Shot Inc	$ 0.122005 (-32.33%)	1.1k
LITMSnow Lake Resources Ltd	$ 1.155 (-27.81%)	45.08M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF	$ 66.74 (-24.56%)	9.05k
NXUNXU Inc	$ 1.98 (713.48%)	456.34M
VINCVincerx Inc	$ 0.3288 (69.48%)	305.17M
XTIAXTI Aerospace Inc	$ 0.0399 (1.01%)	185.44M
WATTEnergous Corporation	$ 1.535 (273.30%)	167.84M
SMXSMX Security Matters Public Company	$ 0.621201 (75.68%)	153.31M